Skip to content

management of the pulmonary diseases based on Persian medicine in patients infected with COVID-19

Evaluation of the effectiveness of dietary plan for pulmonary diseases based on Persian medicine in patients infected with COVID-19

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200105046009N4
Enrollment
80
Registered
2020-07-18
Start date
2020-06-30
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory infection caused by COVID-19. COVID-19, virus not identified

Interventions

Intervention 1: Intervention group: Diet based on the principles of Persian medicine is prepared as a weekly program in three meals and given to patients. In this diet, raw materials (including saffro

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who have one / more of the following symptoms in addition to acute respiratory disease (ARI): • RR> 30 • PO2 <93% • Pulmonary infiltration in chest radiography • Clinical judgment of a specialist doctor Age range 18 to 75 years of both gender The patient's ability and personal desire to fill out the personal consent form to enter the study

Exclusion criteria

Exclusion criteria: any chronic uncontrolled cardiac, renal, metabolic concomitant, etc. The patient with intubation. Nausea and vomiting and oral intolerance Treatment-resistant hypoxemia Decreased level of consciousness Hemodynamic instability

Design outcomes

Secondary

MeasureTime frame
Duration of hospitalization. Timepoint: days of hospitalization. Method of measurement: counting the days from hospitalization to discharge.;Duration of fever. Timepoint: Number of hospitalization days when the patient has a oral fever above 36.6. Method of measurement: The patient's fever is assessed daily with an oral thermometer and the number of days that patients have a fever over 36.6 at the time of hospitalization is counted.;Duration of cough. Timepoint: daily. Method of measurement: Counting the number of days a patient coughs in hospitalized days.

Primary

MeasureTime frame
O2 Saturation rate (percent). Timepoint: Daily. Method of measurement: using pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyedali Mozaffarpur

Babol University of Medical Sciences

seyyedali1357@gmail.com+98 11 3219 4730

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026